Megron ER Tablet (Extended Release)

Megron ER Tablet (Extended Release) 50 mg

Megron ER Tablet (Extended Release) 50 mg is a drug used for the treatment of overactive bladder. It is a type of medication known as a beta 3 agonist, and it works by stimulating beta 3 adrenergic receptors in the bladder, which triggers bladder muscles to relax. Megron ER Tablet (Extended Release) 50 mg helps reduce frequent urination as well as urgency and leakage associated with overactive bladder.

Uses for

Megron ER Tablet (Extended Release) 50 mg is used to treat people who suffer from overactive bladder. It is used to treat symptoms of urine leakage, frequent urination during the day, night, and sudden urges to urinate.

Mechanism of Action

Megron ER Tablet (Extended Release) 50 mg works by stimulating beta 3 adrenergic receptors in the bladder muscles, which signals them to relax. This helps reduce symptoms of overactive bladder such as frequent urination, urgency of urination, and leakage of urine. The drug helps to prevent involuntary contraction of the bladder muscles and improve the patient's bladder control.

How Long Does it Take to Work?

Megron ER Tablet (Extended Release) 50 mg usually starts to work within 1 to 4 weeks after starting the medication, depending on the individual person. Most people feel relief of their symptoms within a few weeks of taking this medicine.

Absorption

Megron ER Tablet (Extended Release) 50 mg is quickly and almost completely absorbed upon oral administration, with peak levels observed about 1.5-2 hours after administration. The drug is quickly distributed to body tissues and has a volume of distribution of 36 liters.

Route of Elimination

Megron ER Tablet (Extended Release) 50 mg is primarily eliminated through the urine. About 65% of the drug is eliminated unchanged in the urine, and about 30% is eliminated as metabolites. About 5% of the drug is eliminated in the feces.

Dosage

Megron ER Tablet (Extended Release) 50 mg is available in tablet form and is usually taken once daily. The recommended starting dose is 25 mg per day, taken with or without food. The dose may be increased to a maximum of 50 mg per day if needed.

Administration

Megron ER Tablet (Extended Release) 50 mg is taken orally with or without food. It is important to take the drug as prescribed by your doctor. Do not stop taking the drug or change the dose without first consulting with your doctor.

Side Effects

Common side effects of mirabegron may include headache, dizziness, dry mouth, abdominal pain, nausea, constipation, and insomnia. Other more serious side effects include increased heart rate, changes in vision, and chest pain.

Toxicity

Even though Megron ER Tablet (Extended Release) 50 mg is generally considered to be safe in therapeutic doses, an overdose of this medication can cause symptoms of toxicity. Overdose symptoms may include headache, dizziness, lightheadedness, fainting, flushing, visual disturbances, difficulty breathing, and increased heart rate. If these symptoms are observed, seek immediate medical attention.

Precautions

It is important to consult your doctor before taking Megron ER Tablet (Extended Release) 50 mg if you have certain conditions, such as high blood pressure, heart problems, or if you are pregnant or breastfeeding. Megron ER Tablet (Extended Release) 50 mg should also be used with caution in people who have kidney or liver problems, as it may worsen these conditions.

Interactions

Alcohol and other drugs may interact with Megron ER Tablet (Extended Release) 50 mg. Tell your doctor about all the medications you are taking, including prescription and non-prescription medications, vitamins, and herbal products as they may interact with Megron ER Tablet (Extended Release) 50 mg.

Disease Interaction

Patients with certain diseases should use Megron ER Tablet (Extended Release) 50 mg with caution. These diseases include high blood pressure, heart problems, and kidney or liver disease. Megron ER Tablet (Extended Release) 50 mg may worsen these medical conditions and should be taken only after consulting with your doctor.

Drug Interactions

Megron ER Tablet (Extended Release) 50 mg may interact with certain medications, including opioids, blood pressure medicines, antibiotics, antifungals, HIV/AIDS medications, and seizure medications. Let your doctor know about any medication you are currently taking before starting Megron ER Tablet (Extended Release) 50 mg.

Food Interactions

Megron ER Tablet (Extended Release) 50 mg is not known to interact with food. However, it is recommended to take it with food to reduce the risk of stomach upset.

Pregnancy Use

Megron ER Tablet (Extended Release) 50 mg is not recommended for use in pregnant women, as it may cause harm to the unborn baby. Women who are pregnant or plan on becoming pregnant should consult their doctor before taking this medication.

Lactation Use

It is unknown whether or not mirabegron is secreted in the breast milk. Therefore, breastfeeding women should consult their doctor before taking this medication.

Acute Overdose

If an acute overdose of mirabegron is suspected, a healthcare provider should be contacted immediately. Symptomatic and supportive measures should be taken as necessary.

Contraindications

Megron ER Tablet (Extended Release) 50 mg is contraindicated in patients who are allergic to this medication, those with uncontrolled hypertension, and those who have severe coronary artery disease. It is also contraindicated in patients with severe liver impairment.

Use Directions

Megron ER Tablet (Extended Release) 50 mg should be taken only under the guidance of your doctor. The usual recommended dose is 25-50mg once daily, taken with or without food. Do not abruptly stop taking this medication without consulting your doctor.

Storage Condition

Megron ER Tablet (Extended Release) 50 mg should be stored at room temperature, away from direct light, moisture, and heat. Do not store in the bathroom. Keep out of the reach of children.